Medium-Term Disability and Long-Term Functional Impairment Persistence in Survivors of Severe COVID-19 ARDS: Clinical and Physiological Insights.

Acute respiratory distress syndrome COVID-19 CT scan Exercise tolerance Lung function

Journal

Archivos de bronconeumologia
ISSN: 1579-2129
Titre abrégé: Arch Bronconeumol
Pays: Spain
ID NLM: 0354720

Informations de publication

Date de publication:
28 May 2024
Historique:
received: 11 03 2024
revised: 09 05 2024
accepted: 14 05 2024
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 9 6 2024
Statut: aheadofprint

Résumé

Although the medium- and long-term sequelae of survivor of acute respiratory distress syndrome (ARDS) of any cause have been documented, little is known about the way in which COVID-19-induced ARDS affects functional disability and exercise components. Our aims were to examine the medium-term disability in severe COVID-19-associated ARDS survivors, delineate pathophysiological changes contributing to their exercise intolerance, and explore its utility in predicting long-term functional impairment persistence. We studied 108 consecutive subjects with severe COVID-19 ARDS who remained alive 6 months after intensive care unit (ICU) discharge. Lung morphology was assessed with chest non-contrast CT scans and CT angiography. Functional evaluation included spirometry, plethysmography, muscle strength, and diffusion capacity, with assessment of gas exchange components through diffusing capacity of nitric oxide. Disability was assessed through an incremental exercise test, and measurements were repeated 12 and 24 months later in patients with functional impairments. At 6 months after ICU discharge, a notable dissociation between morphological and clinical-functional sequelae was identified. Moderate-severe disability was present in 47% of patients and these subjects had greater limitation of ventilatory mechanics and gas exchange, as well as greater symptomatic perception during exercise and a probable associated cardiac limitation. Female sex, hypothyroidism, reduced membrane diffusion component, lower functional residual capacity, and high-attenuation lung volume were independently associated with the presence of moderate-severe functional disability, which in turn was related to higher frequency and greater intensity of dyspnea and worse quality of life. Out of the 71 patients with reduced lung volumes or diffusion capacity at 6 months post-ICU discharge, only 19 maintained a restrictive disorder associated with gas exchange impairment at 24 months post-discharge. In these patients, 6-month values for diffusion membrane component, maximal oxygen uptake, ventilatory equivalent for CO Less than half of survivors of COVID-19 ARDS have moderate-severe disability in the medium term, identifying several risk factors. In turn, diffusion membrane component and exercise tolerance at 6-month ICU discharge are independently associated with the persistence of long-term functional sequelae.

Sections du résumé

BACKGROUND BACKGROUND
Although the medium- and long-term sequelae of survivor of acute respiratory distress syndrome (ARDS) of any cause have been documented, little is known about the way in which COVID-19-induced ARDS affects functional disability and exercise components. Our aims were to examine the medium-term disability in severe COVID-19-associated ARDS survivors, delineate pathophysiological changes contributing to their exercise intolerance, and explore its utility in predicting long-term functional impairment persistence.
METHODS METHODS
We studied 108 consecutive subjects with severe COVID-19 ARDS who remained alive 6 months after intensive care unit (ICU) discharge. Lung morphology was assessed with chest non-contrast CT scans and CT angiography. Functional evaluation included spirometry, plethysmography, muscle strength, and diffusion capacity, with assessment of gas exchange components through diffusing capacity of nitric oxide. Disability was assessed through an incremental exercise test, and measurements were repeated 12 and 24 months later in patients with functional impairments.
RESULTS RESULTS
At 6 months after ICU discharge, a notable dissociation between morphological and clinical-functional sequelae was identified. Moderate-severe disability was present in 47% of patients and these subjects had greater limitation of ventilatory mechanics and gas exchange, as well as greater symptomatic perception during exercise and a probable associated cardiac limitation. Female sex, hypothyroidism, reduced membrane diffusion component, lower functional residual capacity, and high-attenuation lung volume were independently associated with the presence of moderate-severe functional disability, which in turn was related to higher frequency and greater intensity of dyspnea and worse quality of life. Out of the 71 patients with reduced lung volumes or diffusion capacity at 6 months post-ICU discharge, only 19 maintained a restrictive disorder associated with gas exchange impairment at 24 months post-discharge. In these patients, 6-month values for diffusion membrane component, maximal oxygen uptake, ventilatory equivalent for CO
CONCLUSIONS CONCLUSIONS
Less than half of survivors of COVID-19 ARDS have moderate-severe disability in the medium term, identifying several risk factors. In turn, diffusion membrane component and exercise tolerance at 6-month ICU discharge are independently associated with the persistence of long-term functional sequelae.

Identifiants

pubmed: 38853119
pii: S0300-2896(24)00185-6
doi: 10.1016/j.arbres.2024.05.021
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Raquel Casitas (R)

Servicio de Neumología, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Madrid, Spain; Departamento de Medicina, Universidad Autónoma de Madrid, Spain.

Raúl Galera (R)

Servicio de Neumología, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Madrid, Spain; Grupo de Enfermedades Respiratorias, IdiPAZ, Madrid, Spain.

María Torres-Vargas (M)

Servicio de Neumología, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.

Sara Garcia-Tovar (S)

Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Madrid, Spain; Grupo de Enfermedades Respiratorias, IdiPAZ, Madrid, Spain.

Enrique Alfaro (E)

Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Madrid, Spain; Grupo de Enfermedades Respiratorias, IdiPAZ, Madrid, Spain.

Elena Díaz-Garcia (E)

Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Madrid, Spain; Grupo de Enfermedades Respiratorias, IdiPAZ, Madrid, Spain.

Elisabet Martinez-Cerón (E)

Servicio de Neumología, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Madrid, Spain; Grupo de Enfermedades Respiratorias, IdiPAZ, Madrid, Spain.

Miguel Garcia-Garcia (M)

Departamento de Análisis Económico y Economía Cuantitativa, Universidad Complutense de Madrid, Spain.

Isabel Torres (I)

Servicio de Radiodiagnóstico, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.

Marta Núñez-Fernández (M)

Servicio de Neumología, Complejo Hospitalario Universitario de Vigo, Spain; NeumoVigo I+i, Galicia Sur Health Research Institute (IIGS), Vigo, Spain.

Alberto Fernández-Villar (A)

Servicio de Neumología, Complejo Hospitalario Universitario de Vigo, Spain; NeumoVigo I+i, Galicia Sur Health Research Institute (IIGS), Vigo, Spain.

María Fernández-Velilla (M)

Servicio de Radiodiagnóstico, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.

José Manuel Añón (JM)

Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Madrid, Spain; Servicio de Medicina Intensiva, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.

Carolina Cubillos-Zapata (C)

Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Madrid, Spain; Grupo de Enfermedades Respiratorias, IdiPAZ, Madrid, Spain.

Francisco García-Río (F)

Servicio de Neumología, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Madrid, Spain; Departamento de Medicina, Universidad Autónoma de Madrid, Spain; Grupo de Enfermedades Respiratorias, IdiPAZ, Madrid, Spain. Electronic address: fgr01m@gmail.com.

Classifications MeSH